⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 30, 2025Journal of Current Biomedical Reports

From empirical to precision therapy in ICUs: Rethinking antibiotic use after COVID-19

Hossein Azarmina Niloofar Keikhaei Kamyar Kharazmi

View at Publisher

Ask AI

Bookmark

Share

Key Points

Adopting precision therapy may enhance treatment outcomes for ICU patients recovering from COVID-19, optimizing antibiotic use.
The reinspecting of antibiotic strategies addresses the implications of resistant infections in critical care settings like ICUs.
Implementing personalized medicine approaches in antibiotic therapy could significantly improve patient management and recovery rates in ICUs.
Emphasizing precision in antibiotic use after COVID-19 can guide ICU practices and reduce complications from ineffective treatments.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

The shift to precision therapy guides antibiotic use in ICUs, emphasizing optimized treatment regimens for COVID-19 patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Azarmina et al. (2025) studied this question.

synapsesocial.com/papers/68e9b1b5ba7d64b6fc131fe5 https://doi.org/10.61882/jcbior.6.3.331

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1THE USE OF EMPIRICAL ANTIBIOTICS IN THE CRITICAL CARE UNIT2024 · 1 citations
2Precision Approaches to Carbapenem-Resistant Infections in the ICU: Integrating Diagnostics, Stewardship, and Novel TherapiesOriginal Research · 2026 · 1 citations
3An essential component of antimicrobial stewardship during the COVID-19 pandemic in the intensive care unit: de-escalation2024
4754: DURATION AND APPROPRIATENESS OF EMPIRICAL ANTIBIOTIC USE IN ICU: A QUALITY IMPROVEMENT PROJECTOriginal Research · 2026
5Empirical antibiotic therapy in COVID-19 ICU pulmonary coinfections2024 · 1 citations

Early empiric antibiotic use in COVID-19 patients: results from the international VIRUS registry2023
385: OPTIMIZING ICU EMPIRIC COVERAGE: FIVE-YEAR REVIEW OF ANTIBIOTIC RESISTANCE TRENDS IN GRAM-NEGATIVES2026
Empirical antibiotic prescribing in COVID-19 patients: patterns and predictors in a resource-constrained Central Indian setting2026
Microbial dysbiosis and carcinogenesis: Exploring the contribution of the microbiome to major human cancersJournal of Current Biomedical Reports · 2026
Distribution of aminoglycoside-modifying enzyme genes in Escherichia coli isolated from urinary tract infectionsJournal of Current Biomedical Reports · 2026

More from Journal of Current Biomedical Reports